AHA Scientific Sessions 2025 Abstract
Walking Impairment Questionnaire score declines after lower extremity revascularization are linked to adverse cardiovascular events and rivaroxaban dose not affect walking ability
Trial in peopleBiomarkers
The paper
CPC clinical research; CPC Clinical Research
AHA Scientific Sessions 2025 Abstract, 3 Nov 2025
Presented at AHA Scientific Sessions 2025, abstract 4367796
